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ABSTRACT
Post-transcriptional Regulation of RsmA In Pseudomonas aeruginosa
by
Ian Miller
Pseudomonas aeruginosa is an infectious Gram-negative bacillus that is found in a variety of
environments. Gene regulatory mechanisms control the expression of virulence factors that allow
P. aeruginosa to initiate acute infections and persist as a chronic infection of its host. TwoComponent Systems (TCS), transcriptional and post-transcriptional regulators, small non-coding
RNAs (sRNA), mRNA secondary structure, and others are involved in the coordination of
specific virulence genes. A significant post-transcriptional regulator involved in this regulatory
network is the Regulator of Secondary Metabolites (RsmA). In this study, we investigated the
contribution of a putative stem-loop has on expression of RsmA using bioinformatics and
molecular techniques. We constructed rsmA leader fusions to measure translation with and
without the secondary structure present. Secondly, we introduced point mutations in the stem of
the stem-loop of the leader fusions to disrupt the formation of the stem-loop. Finally, we
performed Site-Directed Mutagenesis on the rsmA leader to examine protein levels in vivo by
western blot analysis using an HA-tagged rsmA. Our data suggests that the segment of RNA that
contains the putative stem-loop structure serves some function in post-transcriptional regulation
of RsmA.
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CHAPTER 1
INTRODUCTION
Pseudomonas aeruginosa
Pseudomonas aeruginosa is a metabolically versatile, infectious Gram-negative bacillus
that is found in environments ranging from aerobic to anaerobic, soil to water, plant tissues to
human tissues, and even found thriving on medical implant devices (Stover et al. 2000; LaBauve
and Wargo 2012). P. aeruginosa is ubiquitous in our environment and can infect anyone.
Infections of healthy individuals are less common and are generally acute in nature. Largely an
opportunistic pathogen, P. aeruginosa is a major concern for immunocompromised individuals,
where infections are more severe and can become life-threatening (LaBauve and Wargo 2012).
This population includes those with; diabetes, chronic obstructive pulmonary disease, a recent
surgery, a severe burn, or other ailments that result in a compromised immune system, such as
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), and
cancer (Rizzi et al. 2006; Dubern et al. 2015; Mulcahy et al. 2015). Additionally, individuals
living with cystic fibrosis(CF) experience the highest rate of morbidity and mortality from
chronic lung infections with P. aeruginosa (Mathee et al. 1999). Due to its adaptability and
numerous virulence factors, this bacterium can infect most tissues of the human body (Dubern et
al. 2015). Intrinsic and acquired antibiotic resistance of P. aeruginosa has become a major
concern for hospital acquired infections in the United States, with 51,000 nosocomial infections
per year; based on most recent estimates (CDC 2013). To develop a more efficacious antipseudomonad therapy, many researchers are investigating the possibility of developing antivirulence factor therapies (Fernebro 2011). Understanding gene regulation and the many
regulatory networks of P. aeruginosa is necessary to aid in the development of anti-virulence
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therapies.
Pseudomonas aeruginosa Virulence
Pathogenic organisms utilize virulence factors to initiate colonization of the host, to cause
disease, or persist as an on-going infection. P. aeruginosa possesses an abundance of virulence
factors aiding its ability to cause disease. It can colonize and cause acute infections; such as
keratitis, otitis externa, folliculitis, and pneumonia in relatively healthy individuals (Gellatly and
Hancock 2013). When acute infections are unsuccessfully treated, P. aeruginosa can modify the
expression of virulence factors to produce those that are more suitable for maintaining a chronic
infection (Veesenmeyer et al. 2009). For this reason, virulence factors are often divided into two
categories: those responsible for acute infections, and those responsible for chronic infection.
Thus, a paradigm exists between acute and chronic lifestyles of P. aeruginosa.
In general, acute infections are characterized by a bacteria that are motile, by means of a
single polar flagellum and Type Four Pili(TFP) and secrete effector proteins into host cells by
the Type III Secretion System(T3SS). The flagellum is commonly associated with swimming
motility, but has also been implicated in adhesion to the basolateral surface of host cells,
migration through mucin layers, and biofilm formation (Bucior et al. 2012; Hayashi et al. 2015).
TFP are responsible for twitching motility, attachment to apical surfaces of host cells, and
biofilm formation (Bucior et al. 2012). Additionally, TFP possess a mechanosensory function
that can indirectly increase levels of cyclic adenosine monophosphate (cAMP) (Persat et al.
2015). cAMP is known to be involved in several cellular functions. One function is the activation
of the transcription factor Vfr(Virulence Factor Regulator) by direct binding (Fuchs et al. 2010).
Vfr-cAMP has several downstream targets; one of which is positive regulation of the T3SS
(Fuchs et al. 2010; Persat et al. 2015). The T3SS is a needle-like projection composed of several
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proteins that is used to secrete the effector proteins ExoS, T, U, and Y into the host cell (Hauser
2009). The secretion of these toxins into the host cell results in cessation of DNA synthesis,
disruption of the actin cytoskeleton, degradation of plasma membranes, and many other
damaging effects. Intoxication by these enzymes allows for quicker dissemination of the
pathogen, decreased innate immune function, and host cell death (Hauser 2009). Given this
information, it is apparent how these three virulence factors play a significant role in the initial
colonization and subsequent acute infections by P. aeruginosa
To persist as a chronic infection, such as those found in the CF lung, P. aeruginosa must
adapt to survive and exploit the new niche. Biofilm formation is a tactic used to establish a
lasting infection. P. aeruginosa biofilms are composed of extracellular polymeric
substances(EPS) such as the exopolysaccharides Pel, Psl, and alginate. Other substances include
lipids, proteins, and extracellular DNA. The presence and levels of each component can vary
between different environments, the stresses imposed on the biofilm, and the stage of biofilm
development (Moradali et al. 2017). It is worth noting that Pel and Psl are expressed by both
acute and chronic infecting strains. Involvement of Pel and Psl in biofilm formation is seen in the
early stages of infection aiding adhesion, and is maintained as a structural component of the
mature biofilm seen in chronic infections (Jones and Wozniak 2017). Longitudinal studies of P.
aeruginosa isolates from CF patients have established common genotypes associated with
chronic infection. One particular genotypic variation is the mutation of the anti-sigma factor gene
mucA (Winstanley et al. 2016). Thought to be a result of environmental stresses found in the CF
lung, mutation of mucA results in freeing of the sigma factor AlgU (Figure 1). AlgU, as well as
AlgR, are involved in the activation of the alginate biosynthetic pathway leading to the
production of alginate (Sautter et al. 2012). The cell adopts the mucoidy phenotype, a hallmark
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characteristic of chronic CF isolates (Wu et al. 2004). The importance of biofilms in a chronic
infection are protection from host immune defenses and antibiotic resistance (Gellatly and
Hancock 2013).

Figure 1. Mutation of MucA leads to alginate production and the mucoidy phenotype. A.) The
sigma factor AlgU is sequestered by the anti-sigma factor MucA at the inner membrane. B.)
Mutation of mucA leads to activation of the alginate biosynthetic pathway by AlgU.
An additional chronic state virulence factor extensively studied is the Type VI Secretion
System (T6SS). Resembling the bacteriophage puncturing apparatus, the T6SS secretes effector
proteins directly into target cells. P. aeruginosa has three known types of T6SSs originating from
three genes clusters. They are H1-T6SS, H2-T6SS, and H3-T6SS (Chen et al. 2015). These
secretion systems have utility in both bacteria-bacteria and bacteria-host cell interactions. While
there are numerous effector proteins, for brevity, only a few examples will be mentioned. Type
Six Exported (Tse) 1, 2, and 3 are translocated by the H1-T6SS. Tse1 and 3 cause degradation of
peptidoglycan in bacteria, while injection of Tse-2 causes cessation of cellular growth in
prokaryotes (Russell et al. 2011). H2 and H3-T6SS secrete the effectors PldA and PldB, which
are involved in the invasion of P. aeruginosa into eukaryotic cells and the killing of other
bacterial cells (Sana et al. 2015). Altogether, this system has implications in establishing
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dominance in polymicrobial environments and innate immune evasion (Hood et al. 2010; Sana et
al. 2015).
Motility by TFP and flagellum, and T3SS are characteristic of acute infections. Becoming
sessile and expressing T6SS has been associated with chronic infections. The virulence factors
described here are only a small representation of the arsenal that P. aeruginosa possesses. Cues
that drive this transition between acute and chronic phenotypes vary from numerous
environmental stresses to cell population density, and at the root of it all are various complex
mechanisms that shift the continuum of gene expression.
RsmA and Post-Transcriptional Regulation
To thrive, pathogenic and non-pathogenic bacteria must be able to respond quickly to
changes in their environment. This is achieved through rapid modulation of gene expression that
can result in adaptive phenotypic changes (Jean-Pierre et al. 2017). At the time of its complete
genome sequence, P. aeruginosa had the highest proportion of predicted regulatory genes of all
sequenced bacterial genomes (Stover et al. 2000). Housekeeping and virulence associated genes,
are controlled by complex regulatory systems composed of Two-Component Systems (TCS) and
transcriptional and post-transcriptional regulators. These regulators specifically include, DNA
and RNA binding proteins, small non-coding RNAs (sRNA), intrinsic RNA secondary structures
(stem-loops and riboswitches), and others (Romeo 1998; Svensson and Sharma 2016). Posttranscriptional regulation is one scheme bacteria use to rapidly alter gene expression in a
changing environment.
A significant post-transcriptional regulator involved in global gene expression in P.
aeruginosa is Repressor of Secondary Metabolites (RsmA) (Pessi et al. 2001). RsmA is a
homologue to Carbon Storage Regulator (CsrA), belonging to the Carbon Storage Regulator
13

(Csr) family of mRNA binding proteins found in both Gram-positive and Gram-negative bacteria
(Yakhnin et al. 2007). In bacteria, the first step in protein synthesis, after mRNA transcription, is
recognition of the Ribosomal Binding Site(RBS) or Shine Dalgarno(SD) sequence by the 16s
rRNA within the 30s ribosomal subunit. After binding of the RBS by the 30s subunit, the 50s
ribosomal subunit will join the 30s subunit making a complete 70s ribosome. Translation can
begin once the 70s ribosome has assembled (Laursen et al. 2005). This process is interrupted
when CsrA/RsmA bind their recognition sites within the 5’ Untranslated Region (UTR) of
mRNAs. It is generally accepted that CsrA/RsmA recognize GGA motifs located in the loop of
stem-loops and impose their activity by binding GGAs that overlap the RBS (Figure 2) thus,
inhibiting interactions of the 30s ribosomal subunit to the target mRNA (Baker et al. 2002).

Figure 2. RsmA inhibits translation by recognizing and binding GGA motifs presented in the
loop of stem-loops present in 5' Untranslated Regions of target mRNAs.
The example just described is known as repression of translation initiation. This was first
described for CsrA in the repression of glgC, a gene involved in glycogen biosynthesis (Baker et
al. 2002). Since then, other mechanisms whereby CsrA represses or activates gene expression
have been described. For example, CsrA mediates expression of the pgaABCD operon; necessary
for biofilm formation, by translation repression, transcription attenuation, and indirectly
represses expression by targeting an mRNA that encodes an activator of the pgaABCD operon
(Romeo and Babitzke 2018). Conversely, the transcript for the flhDC operon; which is
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responsible for flagella biosynthesis, is stabilized by bound CsrA, leading to flagellar motility
(Wei et al. 2001).
Like CsrA, RsmA has been implicated in the regulation of several hundred genes in P.
aeruginosa. A microarray study performed in 2006 determined that RsmA was involved in the
regulation of 506 out of 5570 genes analyzed in the PAO1 reference strain versus an rsmA
mutant (Burrowes et al. 2006). Another study in 2009 examined strain PAK and found that 528
of 5678 gene were affected by RsmA (Brencic and Lory 2009). Interestingly, only 67 genes
overlapped between the two strains, which was partially attributed to varied growth conditions
(Brencic and Lory 2009).
In both studies, transcript levels of T3SS and TFP operons were decreased in the rsmA
mutant. In their 2009 study, Brencic and Lory analyzed their findings by transcriptional and
translational fusions using genes found in both operons. Of the genes analyzed, all showed
decreased levels of transcription in the rsmA mutant but showed no difference in the translational
fusions. In addition, purified RsmA did not bind the mRNA of the selected genes in their gel
mobility assay (Brencic and Lory 2009). These data suggest RsmA is involved in the positive
expression of type three secretion and twitching motility by TFP, albeit indirect. In this case, it is
possible that RsmA is inhibiting translation of a transcriptional regulator of both T3SS and TFP.
The rsmA mutation had a positive effect on components of the H1-T6SS, PA0081 and
PA0082. In light of this finding, Brencic and Lory set out to determine if RsmA had direct posttranscriptional regulation on the H1-T6SS. mFold analysis revealed RsmA binding sites within
the 5’UTRs of PA0081 and PA0082 and both mRNAs co-purified with RsmA. Also, RsmA
binding to the mRNA was confirmed with gel mobility assays, concluding that RsmA directly
inhibits translation of these messages (Brencic and Lory 2009).
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Biofilm biosynthesis is repressed by RsmA indirectly and directly. Increased levels of cdi-GMP result in a less motile phenotype and one that produces biofilms. The diguanylate
cyclase, SadC, is controlled by RsmA. Western blot analysis determined that when RsmA is
sequestered by RsmY, SadC is present. However, when RsmA is abundant SadC is not
detectable (Moscoso et al. 2014). Therefore, RsmA represses biofilm production indirectly by
controlling c-di-GMP levels through SadC. Psl is negatively regulated by RsmA. A study has
shown that RsmA is involved in stabilizing an anti-SD and SD interaction by binding the singlestranded region of a stem-loop with a GGA motif whereby translation is directly repressed (Irie
et al. 2010).
Since RsmA is an mRNA binding protein that functions post-transcriptionally and these
experiments examined the transcriptional difference between wildtype and a rsmA mutant, the
results only suggest that RsmA indirectly affects a broad range of genes. The majority of the
targets have not been confirmed by direct RsmA binding; nonetheless, these two studies
demonstrated the expansive role RsmA has on global gene expression in P. aeruginosa.
Categories affected included iron acquisition and storage, antibiotic resistance, stress response,
and quorum sensing, and others. More importantly, RsmA is involved in the regulation of
virulence factors, which include: TFP, T3SS, T6SS, and biofilm biosynthesis (Brencic and Lory
2009). Recall, TFP and T3SS are associated with acute infections and T6SS and biofilms are
characteristic of chronic infections. Thus, RsmA plays a role in shifting P. aeruginosa’s
phenotypes between acute and chronic infections.
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Gene Regulation by RNA & RNA Secondary Structures
Beyond gene regulation at the transcriptional and post-transcriptional level by DNA and
mRNA binding proteins, RNA and their secondary structures have emerged as crucial elements
in gene expression. RNA regulation comes in many forms. They can be small non-coding
RNAs(sRNAs) that are cis- or trans-acting elements, they can exist as intrinsic secondary
structures in the 5’ and 3’UTRs of mRNAs, or as dual-functioning mRNAs that have a coding
region and also function as trans-acting elements. These RNAs are gaining more attention for
their involvement in gene expression as many are associated with virulence and survivability in
various environments (Svensson and Sharma 2016). Most known examples of gene regulation by
RNAs are found at the post-transcriptional level; however, regulation at the transcriptional level
does occur. Demonstrated in E. coli, when the σ70 subunit of RNA Polymerase(RNAP) is bound
by the 6S sRNA, transcription for genes that have promoters recognized by the σ70 sigma factor
were reduced (Wassarman and Storz 2000). sRNAs have multiple functional mechanisms when
it comes to post-transcriptional regulation. In the simplest form, sRNAs can bind target mRNAs
with great complementarity using cis-acting sRNAs, or to a lesser degree of complementarity
with trans-acting sRNAs. Using their base-pairing affinity, the sRNAs aid in the inhibition or
activation of protein translation. Additionally, protein activity can be altered by sRNA
interactions (Svensson and Sharma 2016). For example, the sRNAs RsmY and RsmZ are known
to sequester RsmA, thus imposing indirect post-transcriptional regulation (Lapouge et al. 2008).
Intrinsic secondary structures within UTRs provide numerous modes of gene expression.
It is largely accepted that mRNAs among bacterial species have relatively short 5’UTRs,
generally 20-40 nucleotides in length. mRNAs with longer 5’UTRs typically show greater
potential for formation of secondary structures and post-transcriptional regulation (Svensson and
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Sharma 2016). Secondary structures possess regulatory functions in the form of mRNA stability,
thermosensors (RNA thermometers), and riboswitches, to name a few examples (Svensson and
Sharma 2016).
Protein synthesis requires time and energy. First, mRNA must be transcribed from DNA.
Then, mRNA must be translated into protein. At the time of an environmental shift, such as
infecting a host, there are many cues received that induce a shift in gene expression. Therefore,
regulating gene expression at a post-transcriptional level afford bacteria a more rapid and
efficient response. The presence and abundance of mRNA in a cell can dictate the level of
expression of the gene product. Therefore, the degradation or stability of mRNA is important in
controlling levels of gene expression (Hui et al. 2014).
Bacteria use a panel of nucleases to degrade unwanted mRNA, thus decreasing gene
expression. These nucleases can be 5’ or 3’ exonucleases, endonucleases, and oligonucleases
(Hui et al. 2014). Nucleases have various requirements to inflict their function on mRNAs. For
example, the phosphorylation state, monophosphorylated vs. triphosphorylated 5’ ends of target
mRNA allows endolytic cleavage by RNaseE (Celesnik et al. 2007). Additionally, RNaseE
preferentially cleaves A/U rich single-stranded RNA. Some nucleases, like RNase III, cut
double-stranded RNA like that found in stem-loops (Hui et al. 2014). Some nucleases are not
able to completely degrade their targets, so oligonucleases finish degrading short fragments of
RNA (2-5 nucleotides) to mononucleotides. Degrading RNAs down to single nucleotides is
energetically beneficial to the organism as it replenishes the RNA precursor pool (Hui et al.
2014). Just as it is important to degrade unwanted messages, it is also important for some
mRNAs to possess longevity. mRNAs are stabilized through 5’ and 3’ secondary structures.
Take for example RNaseE, which again prefers mRNA with a 5’ monophosphate and cleaves

18

single-stranded A/U rich regions. In this example a 5’ stem-loop provides protection from
RNaseE endolytic attack (Hui et al. 2014). In another example, stem-loops can provide binding
sites for trans-acting elements that prevent nucleolytic cleavage. CsrA has been shown to
increase the half-life of the flhDC mRNA by binding two sites upstream of an RNase E cleavage
site and preventing degradation (Yakhnin et al. 2013). Stem-loops found at the 3’ end of full
length mRNAs protect the messages from 3’exonucleases which will require nucleases to begin
degradation in other locations (Hui et al. 2014). Degradation of mRNAs by nucleases is an
indiscriminate process. Structured segments within 5’ and 3’ UTRs of mRNAs can provide
protection from some nucleases while providing a target for others.
Some human pathogens have developed genetic mechanisms for regulating the
expression of certain genes in a temperature dependent manner (Grosso-Becerra et al. 2014).
Many of these genes are involved in the positive regulation of virulence factors or encode heat
shock proteins (Grosso-Becerra et al. 2014). There are two well-characterized RNA
thermometers identified in several bacteria. They are the Repression Of heat-Shock gene
Expression (ROSE) element and the Four-U RNA thermometer (Svensson and Sharma 2016).
The ROSE element is an RNA thermometer that can range in length, from 60 to over 100
nucleotides, and composed of several (2-4) stem loops (Figure 3). The stem-loops proximal to
the translation initiation site sequester the Ribosomal Binding Site (RBS). They are stable at low
temperatures and prevent translation of the mRNA. At higher temperatures, like those
experienced during infection of the human host, translation of the message can occur because the
stem-loop occluding the RBS will melt (Grosso-Becerra et al. 2014). The other RNA
thermometer, Four-U (Figure 3), uses a UUUU motif to bind the RBS and forms a stem-loop
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(Waldminghaus et al. 2007). Like the ROSE, the stem-loop is stable at lower temperatures but
melts at higher temperatures to allow expression of the gene under its control.

Figure 3. RNA thermometers regulate mRNA translation in a temperature dependent manner by
occluding the Ribosomal Binding Site (RBS) at lower temperatures. Temperature increases lead
to exposure of the RBS. A.) The Repression Of heat-Shock gene Expression (ROSE) consists of
several stem-loop structures in the 5' Untranslated Region. The most 3’ stem-loop will occlude
the RBS. B.) The Four-U RNA thermometer uses four Uracil ribonucleotides to loosely base-pair
with the RBS.
Riboswitches are genetic regulators of various biosynthetic pathways found in the 5’UTR
of mRNAs(Figure 4). These structured regulatory elements affect transcription or translation of
the mRNA, generally by sensing metabolites, pathway intermediates, or products related to the
translated mRNA (e.g. vitamins, purines and derivatives, amino acids, some metals (Mg2+), some
anions (F-), and others) (Serganov and Nudler 2013). There are two components of a riboswitch;
the aptamer and the expression platform. The main mechanism for riboswitch activity is the
conformational change that occurs at the expression platform when the aptamer binds its ligand
(Svensson and Sharma 2016). Transcriptional regulation by riboswitches occurs in the formation
of Rho-dependent and independent terminators and antiterminator hairpins. Translational
regulation is achieved by RBS accessibility or exposure to various enzymatic cleavage sites
(Serganov and Nudler 2013; Svensson and Sharma 2016).
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Figure 4. Riboswitches are structed elements in the 5’UTR of mRNAs. A.) The aptamer has not
bound its ligand and the expression platform is available and translation of the message can
proceed. B.) The aptamer has bound its ligand resulting in a conformational change of the
riboswitch. The expression platform is now occluded, and translation is inhibited.
Bacteria possess many mechanism for controlling the expression of their genes. Stability
or degradation of mRNA after transcription allows the bacterium to efficiently modulate gene
expression at a post-transcriptional level. Intrinsic secondary structures within the 5’ UTR can
provide binding sites for cis or trans-acting elements like sRNAs and mRNA binding proteins.
They can also provide protection or enhance nucleolytic activity (Hui et al. 2014). These
mechanisms are important to understand and further investigate as they are involved in many
cellular processes, including virulence gene regulation.
Regulation of RsmA
The GacS/GacA Two-component systems (TCSs) has been established as a major
influence on post-translational regulation of RsmA. The main components of a TCS are the
sensor histidine kinase (SK) and response regulator (RR). P. aeruginosa has 64 SKs, 72 RRs
(Francis et al. 2017). The inner membrane bound SK senses the environment for numerous
signals (e.g. ions, antimicrobial peptides, kin cell lysates, c-di-GMP, and others). Under
appropriate conditions the SK is autophosphorylated on a conserved histidine residue and will
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trigger a phosphorelay directly to its response regulator, or in some cases via a Histidine
Phosphotransfer(Hpt) protein (Francis et al. 2017). The GacS/GacA system works as a
multikinase network involving the SKs LadS, PA1611, and the GacS inhibitor, RetS. Levels of
phosphorylated GacA are controlled through the various SKs (Francis et al. 2017). Once
phosphorylated, GacA acts as a transcriptional regulator and positively regulates two small noncoding RNAs, RsmY and RsmZ (Figure 5). RsmY/Z possess multiple binding sites for RsmA
and sequester RsmA (Lapouge et al. 2007). Therefore, the GacS/GacA TCS is capable of
titrating levels of RsmA through increasing or decreasing RsmY/Z levels in the cell.

Figure 5. The GacS/GacA Two Component System is a multi-sensor histidine kinase system
with the central response regulator, GacA, being phosphorylated by GacS. The small non-coding
RNAs RsmY and RsmZ are activated by GacA. RsmY/Z titrate levels of RsmA in a Posttranslational manner by presenting multiple GGA motifs in the loops of stem-loops.
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Recent studies have established a mechanism by which rsmA is regulated at a
transcriptional level. Through primer extension experiments, a previous study established the
existence of an additional Transcriptional Start Site(TSS) for rsmA 46 nucleotides upstream of a
previously identified putative RpoD dependent TSS and the presence of two different length
rsmA mRNA transcripts via RNase protection assay(RPA) (Stacey and Pritchett 2016).
Interestingly, more mRNA is observed in the mucoid (mucA22) background. The information
gained from the primer extensions and RNase protection assay prompted the examination of the
intergenic region between rsmA and the upstream gene lysC. Initially, a transcriptional fusion
spanning the entire intergenic region was constructed and assayed in PAO1 and mucA22. The
fusion data was in alignment with the data obtained from the RPA indicating more RsmA
transcript in mucA22. Since two TSSs and two messages were observed, two more TFs were
constructed in conjunction with the observed TSSs with additional upstream nucleotides to
encompass promoter regions. Reporter activity from the more distal fusion was significantly
increased over PAO1 in the mucA22 background, whereas no difference was seen between
PAO1 and mucA22 in the more proximal fusion. Conserved AlgU binding motifs upstream of the
distal TSS prompted the examination of the TFs in an AlgU mutant. In both fusions containing
the distal TSS and promoter region, significant decreases in reporter activity were observed in
the mucA22 algU double mutant. Western blot analysis confirmed that there are higher levels of
RsmA in mucA22 relative to PAO1, and deletion of algU significantly reduced intracellular
levels of RsmA. Lastly, mutagenizing the AlgU -35 binding site significantly reduced reporter
activity in mucA22 (Stacey and Pritchett 2016). Thus, these data provide evidence that RsmA is
under the control of the alternative sigma factor AlgU.
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In a similar fashion, using the same TFs a later study determined that the transcription
factor AlgR is also involved in the expression of RsmA in Pseudomonas aeruginosa. AlgR is the
RR in the AlgZ/R TCS. To test if rsmA was under the transcriptional control of this TCS, the TFs
were assayed in an algZ mutant. No difference was seen between mucA22 and the mucA22 algZ
double mutant (Stacey et al. 2017). Also, since AlgR can be phosphorylated by AlgZ, AlgR
phosphomimetic and phosphodeficient strains were engineered so that AlgR structural
conformation in a constant phosphorylated or unphosphorylated could be analyzed. The study
concluded that rsmA is activated at a transcriptional level by unphosphorylated AlgR and RsmA
is not under the control of the AlgZ/R TCS (Stacey et al. 2017). These two studies have
furthered our understanding of the transcriptional controls overlying the expression of rsmA. The
microarray data by Brencic and Lory, and Burrowes and colleagues has given insight into the
RsmA regulon, yet there are still gaps in our knowledge of rsmA expression.
Due to the discoveries described above, in this study I took a post-transcriptional
approach to further investigate the regulation of rsmA in Pseudomonas aeruginosa. Using
bioinformatics, translational leader fusion analysis, site-directed mutagenesis, and western blot
analysis, I provide evidence that the RsmA transcript is under post-transcriptional regulation.
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CHAPTER 2
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Pseudomonas aeruginosa strain PAO1 was selected to represent the nonmucoid wildtype
strain. mucA22 was used to represent mucoid strains commonly isolated from the CF lung. New
England Biolabs 5-alpha (NEB®5-α) Escherichia coli competent cells were used for plasmid
propagation and conjugation. When necessary, pRK2013 was used for triparental mating. Unless
stated otherwise, all strains were incubated at 37˚C with shaking at 250rpm under aerobic
conditions. E. coli strains were grown and maintained on Luria-Bertani (LB). Pseudomonas
Isolation Agar (PIA) was used for the growth and maintenance of P. aeruginosa strains.
Antibiotics were used for selection, at appropriate concentrations, when necessary (Appendix A).
All strains were stored in cryo-tubes at -80˚C in 30% (v/v) glycerol (Appendix B).
Colony PCR
In this study, site-directed mutagenesis and fusion construction was performed. In order
to screen for the mutations and fusions, colony PCR was performed. From an overnight streak
plate, a single colony was selected and resuspended in 50µL of sterile ddH2O in a microfuge
tube. The colony was vortexed and then placed in a heat block set to 65˚C for 10 minutes. While
the cell suspension was heating, the master mix was prepared on ice. After 10 minutes of
heating, 2µL of the cell suspension was added to a thin-walled PCR tube followed by 23µL of
master mix. The PCR reaction tube was placed in a thermocycler with a heated lid and the
program was adjusted to the appropriate settings.
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Table 1. Standard Colony PCR Protocol

Genomic DNA Isolation
Overnight cultures were prepared in 5ml of LB broth. On day two, the cells were pelleted
using a centrifuge set to 8000XG for 10 minutes. The spent LB was removed and the cells were
resuspended in 400µl of 1X TNE and transferred to a microfuge tube. Next, 17µl of sarkosyl
30% (w/v) and 5µl Proteinase K 10mg/ml were added and the suspension was incubated at 37˚C
for 1 hour. After incubation, 400µl of 4M Ammonium Acetate (NH4OAc) was added and the
suspension was mixed by inversion. Cell debris were pelleted using a centrifuge set at 14,000XG
for 10 minutes. The supernatant was carefully removed and placed in a new microfuge tube. Two
washes were performed with 1:1 phenol-chloroform; centrifuging and transferring the aqueous
phase to a new microfuge tube each time. One wash with 600µl of chloroform was performed,
mixed by inversion, and centrifuged. The aqueous layer was transferred to a new microfuge tube
and the genomic DNA was precipitated using 2.5 volumes of chilled absolute ethanol and
incubated at -20˚C for no less than 10 minutes. The DNA was pelleted using a centrifuge set at
13,000XG for 10 minutes. The absolute ethanol was removed, and the DNA pellet was washed
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with 1 ml of 70% ethanol and pelleted again. The 70% ethanol was carefully removed so not to
dislodge the pellet. Finally, the DNA was resuspended in 50µl of 1X TE and stored at 4˚C.
Plasmid DNA Isolation
Overnight cultures were prepared in 5ml of LB broth with suitable antibiotics. On day
two, the cells were pelleted using a centrifuge set to 8000XG for 10 minutes. The spent LB was
removed and the cells were resuspended in 150µl of 1X TE. The suspension was transferred to a
microfuge tube and 10µl of 10mg/ml RNase A was added. To lyse the cells, 300µl of 1% SDS /
0.2M NaOH was added to the suspension and then incubated on ice for five minutes. A volume
of 225µl of 5M potassium acetate / 11.5% acetic acid added to the mixture, mixed by inversion,
and returned to ice for five minutes. Cellular debris were pelleted via centrifugation (13,000XG
for 10 minutes) and the supernatant was transferred to a new microfuge tube. 600µl of PhenolChloroform-Isoamyl alcohol (24:25:1) was added to the supernatant, vortexed, and then
centrifuged for 5 minutes. The aqueous phase was removed and transferred to a new tube,
followed by two washes with 600µl of Chloroform, removing the aqueous layer and transferring
to a new microfuge tube each time. The plasmid DNA was precipitated using 1ml of chilled
absolute ethanol. The solution was incubated on ice for 10 minutes and then the plasmid DNA
was pelleted by centrifugation. The absolute ethanol was removed, the pellet was washed with
70% ethanol and re-pelleted. The 70% ethanol was removed, and the plasmid DNA was left to
air dry. The plasmid DNA was resuspended in ddH2O (20-50µl) and stored at -20˚C or 4˚C.
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Site-Directed Mutagenesis
For deletion:
The suicide vector pEX18gm containing the rsmA coding region with a 3’ hemagglutinin
(HA) tag (pEX18gmrsmAHA) with 1kb flanking either side of rsmA was used as template for the
construction of stem-loop deletion mutants. E. coli harboring pEX18gmrsmAHA was grown on
LB gentamycin15. A single isolate was selected to inoculate a 5ml LB gentamycin15 broth and
grown overnight at 37˚C with shaking. The plasmid DNA was isolated and quantified via
nanodrop. Forward and reverse primers were designed with the 5’ ends back-to-back, flanking
the desired nucleotide deletions (Table 5, Appendix C). A separate 25µl inverse PCR reaction
was assembled on ice for each desired stem-loop deletion, following the protocol in (Table 2).

Figure 6. Concept for site-directed mutagenesis of 5’ UTR deletion mutations by inverse PCR.
A.) A Forward (F) primer with complementarity to zone 3 and a reverse (R) primer with
complementarity to zone 1 amplify the entire plasmid in opposite directions resulting in linear
double stranded plasmids. B.) Linear plasmids maintain zones 1 and 3, while zone 2 is not
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amplified. Endonuclease DpnI is added to the tube to digest template plasmid. C.) Mutagenized
plasmids are circularized, joining zones 1 and 3, using the standard ligation protocol (Table 3).
After completion of PCR, each reaction was digested for one hour with the methylation
sensitive endonuclease, DpnI, to rid the reaction of template plasmid. Next, a ligation reaction
was set up following standard protocol (Table 3) to re-circularize and ligate the ends of the
plasmid (Figure 6). Plasmids were transformed into NEB®5-α competent cells following
standard protocol. Mutant transformants were incubated overnight on LB gentamycin15. The
following day, transformants were picked from the LB gentamycin15 and patched onto the same
media. Newly patched colonies were allowed to incubate overnight at 37 ˚C. PCR was used to
amplify a region of the plasmid approximately 400bp upstream of the rsmA start codon through
the HA allele at the end of rsmA, resulting in an amplified fragment of approximately 600bp
(Table 5, Appendix C). In each case, a native BamHI endonuclease site was deleted from the
amplified region and was used as a marker for proper deletions (Figure 11. A). All mutated
plasmids were sent to the ETSU Molecular Biology Core for sequencing.
Table 2: Site-Directed Mutagenesis Thermocycler Protocol
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For substitution:
To mutate the stem-loop by nucleotide substitution, forward primers with the desired
substitutions were designed and paired with a common reverse primer (Table 5, Appendix C).
Using the standard PCR protocol (Table 1) each substitution was made by amplifying the rsmA
leader region from the distal transcriptional start site through the second codon of rsmA. After
amplification, each fragment and the cloning vector, lacUV5CTX.CP, was double digested with
endonucleases EcoRI and ScaI overnight, following standard protocol. The next day, the
fragments were individually ligated into lacUV5CTX.CP, creating the lacUV5rsmAlacZ
translational leader fusions with nucleotide substitutions. Plasmids were transformed into
NEB®5-α competent cells following standard protocol. Plasmids were sent to the ETSU
Molecular Biology Core for sequencing.
Vector Digest and Ligation
The expression vector lacUV5CTX.CP and desired inserts were individually double
digested with appropriate enzymes to obtain the proper ends desired. Double digest reactions
were assembled (Table 3) and then incubated for at least 1 hour at 37˚C. Enzymes were heat
inactivated, if possible, and products to be cloned were purified using the New England Biolabs
Monarch® DNA Gel Extraction Kit. After purification, DNA quantities of insert and vector were
determined using a Thermo Fisher Scientific NanoDrop™ spectrophotometer. Using Promega
Biomath Calculators for ligation, a 1:3 molar ratio of vector to insert was calculated. The ligation
reaction was assembled (Table 3) and then incubated at room temperature for 2 hours or
overnight at 4˚C.
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Table 3: Double Digest & Ligation Mix

Transformation
NEB®5-α competent cells were thawed on ice. In each transformation, 50µl of thawed
competent cells were transferred to a thin walled PCR tube and mixed with 5µl of post-ligation
(plasmid/insert) by flicking the tube 3-5 times and incubated on ice for 30 minutes. The mixture
was heat shocked using a heat block set at 42˚C for 30 seconds and then immediately placed back
on ice for 5 minutes. The mixture and 950µl of room temperature LB (2 per transformation) were
combined in a microfuge tube and incubated with shaking for 60 minutes for recovery. LB plates
supplemented with appropriate antibiotics were incubated at 37˚C for the duration of the
recovery. After 60 minutes, 100µl of the transformed cells were spread on a selection plate. The
remaining 900µl were centrifuged at 3000XG for 5 minutes. 800µl of the spent LB was removed
and the cells were resuspended and plated with the remaining 100µl of LB. The plates were then
incubated overnight at 37˚C.
Triparental Mating
Triparental mating was used to efficiently transfer vector DNA from E. coli to P.
aeruginosa for the purpose of introducing translational leader fusions or mutations into the
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chromosome. PAO1 or mucA22 was grown overnight at 42˚C on PIA. NEB5α E. coli with
desired vector was grown overnight at 37 ˚C on LB with appropriate antibiotics. The helper strain
pRK2013 was grown overnight at 37 ˚C on LB Kan50. After incubation, the three strains were
removed from the plates with an inoculation loop and resuspended together in a microfuge tube
containing 500µL of 0.85% (w/v) saline. The bacterial suspension was plated on LB and
incubated overnight at 30 ˚C. The following day, the bacteria was collected from the plate with an
inoculation loop and resuspended in 500µL of 0.85% (w/v) saline. To select for the
Pseudomonas strain that successfully took in the vector, 100µL of the suspension was spread
plated onto PIA with the appropriate antibiotics. The vector will provide Pseudomonas with
antibiotic resistance; therefore, the Pseudomonas that did not take up the vector will be removed
from the pool. The spread plate was incubated overnight, or up to 48hours, at 37 ˚C. If colonies
did not appear after 48 then the plate was discarded and the triparental mating was repeated.
Insertion of Translational Leader Fusion
The translational fusion vector used is a derivative of the mini-CTX integration vector.
This vector contains Flp recombinase recognition sites (FRT) flanking the desired insertion
sequence and the φ CTX attachment site, attP. After integration of the plasmid into the attB site(
φ CTX attachment site) in the chromosome of Pseudomonas, the extra unwanted portion of the
plasmid must be removed. This will leave behind the fusion, and remove the integrase,
tetracycline resistance, and origin of replication.
To begin, a Pseudomonas colony grown on tetracycline supplemented PIA was picked
and streaked onto YT tetracycline50irgasan25, and grown overnight at 42 ˚C. Meanwhile, E. coli
with the plasmid encoding Flp recombinase(pFLP2) was grown overnight at 37 ˚C on LB
ampicillin100. Both strains were scraped from their plates with an inoculation loop and
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resuspended in 500µL of 0.85% (w/v) saline. The suspension was plated on LB and incubated
overnight at 30 ˚C. The bi-parentally mated bacteria were removed from the plate and
resuspended in 500µL of 0.85% (w/v) saline. Pseudomonas colonies were isolated by streaking
50 µL of the suspension onto Vogel-Bonner Minimal Media (VBMM) carbenicillin300. After
overnight incubation at 37 ˚C, the colonies were patch plated onto PIA and YT
tetracycline50irgasan25. Successful removal of the unwanted plasmid is determined by loss of the
tetracycline resistance gene, resulting in tetracycline sensitive colonies. Tetracycline sensitive
colonies were screened for the fusion via PCR.
Insertion of Deletion Mutation
During triparental mating with a suicide vector harboring a deletion mutation,
homologous recombination occurs. This results in the same cell having two alleles for the same
gene. This cell is referred to as a merodiploid. In this state, the cell must discard one copy of the
gene; as it is undesirable to have multiple copies of the same gene. Therefore, after selecting for
Pseudomonas colonies with appropriate antibiotic resistance, the colonies will have a period of
recovery in LB broth without antibiotic pressure for a second cross-over event. During this time,
the cell will discard either the wild-type gene or the mutated genetic sequence and keep the
other. The suicide vector used, pEX18, contains the levansucrase encoding gene, sacB. This gene
is used, in this case, as a counter-selectable marker. Bacteria that do not succeed at this second
cross-over still encode the sacB gene or are wild-type. The production of levansucrase cleaves
the sucrose present in the media. This results in the buildup of levans in the cells which becomes
lethal.
A Pseudomonas colony was picked from the antibiotic supplemented PIA plate and
placed in a microfuge tube containing 1mL of LB. The suspension was incubated at 37˚C with
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shaking at 250rpm for greater than one hour. Next, 50µL of the bacterial suspension was
streaked for isolation on YT 10% sucrose and grown overnight at 30 ˚C. Colonies that survive
selection on YT 10% sucrose are patch plated on PIA and antibiotic supplemented PIA.
Antibiotic sensitive colonies were PCR screened for the desired mutation. Given that a BamHI
endonuclease site was removed from the mutated region in this study, subsequent restriction
digests using BamHI was used to distinguish wild-type from mutant.
β-Galactosidase Assay
A Pseudomonas isolate was inoculated into 5ml of LB broth and incubated for 12-18
hours at 37˚C with shaking. A 1% inoculum was used to subculture the strain into 5ml of fresh
LB broth and grown for an additional 8 hours at 37 ˚C with shaking. Assays were performed by
first, collecting and pelleting 500µl of the subculture at 8000XG for 10 minutes. The cell pellet
was resuspended in 1ml of Z-buffer/2.7% β-mercaptoethanol and the optical density was
measured at a wavelength of 600nm using a spectrophotometer. Permeabilization of the cells was
achieved by adding 50µl of 0.1% SDS and 100µl of chloroform. The suspension was vortexed
and incubated at room temperature for 10 minutes. Cell lysate was removed, 20-500µl, placed in
a new microfuge tube and brought to 1ml with Z-buffer-2.7% β-mercaptoethanol. A 4mg/ml
solution of 2-nitrophenyl-β-D-galactopyranoside (ONPG) in Z-buffer was prepared. For every
reaction in each assay, 200µl of ONGP solution was added and a stopwatch was started. Once a
pale-yellow color developed, 500µl of 1M Na2CO3 was added to end the reaction, the stopwatch
was stopped, and the time recorded. The optical density was measured once more at wavelengths
of 420nm and 550nm. The time (t), volume of lysate used (v), and the three optical density
values were used to calculate Miller Units using the following equation:
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Miller Unit = 𝟏𝟎𝟎𝟎 ×

𝑶𝑫 𝟒𝟐𝟎𝒏𝒎−(𝟏.𝟕𝟓×𝑶𝑫 𝟓𝟓𝟎𝒏𝒎)
𝐭×𝐯×𝑶𝑫 𝟔𝟎𝟎𝒏𝒎

Western Blot Analysis
Three mutation constructs were created using site-directed mutagenesis. The vector
pEX18GMrsmAHA was used as template. Each construct deletes different lengths of the 5’ UTR
of rsmA within the proposed stem-loop region (Figure 11). Strains PAO1 and mucA22 were
conjugated via triparental mating with each of the three mutant constructs. Strains were
confirmed by first amplifying a region of approximately 600bp using primers rsmASDMFcheck
and HAR. This colony PCR confirms the presence of the rsmA HA epitope tagged allele.
Secondly, the PCR fragments were digested using the endonuclease BamHI. Fragments that do
not digest into two pieces indicate that the deletion mutation is present.
PAO1 and mucA22 strains harboring the deletion mutation were grown overnight in 5mL
LB broth cultures at 37˚C with shaking. Using a 1% inoculum (100µL) of the overnight culture,
10mL LB broths were setup for growth at 37 ˚C with shaking for 8 hours. Cells were pelleted by
centrifugation at 8000XG for 10 minutes. The supernatant was removed, and the cell pellets were
frozen at -20˚C for at least 4 hours. All subsequent steps were performed on ice. Cell pellets were
thawed and resuspended with 1mL of 0.85% saline. The suspensions were transferred to 2mL
microfuge tubes. Thirty microliters of 20mg/mL lysozyme were added to the suspension, and
then the total volume was brought up to 2mL with 0.85% saline. Enzymatic lysis of the cells
lasted for 10 minutes. Three rounds of sonication, 20 seconds each, with at least 1 minute of rest
in between each step was performed on every sample. After sonication, whole cell lysates were
centrifuged at 8000XG for 10 minutes. Supernatant was transferred to fresh 2mL microfuge
tubes and the protein content was quantified via Bradford Assay following manufactures
protocol.
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Ten nanograms of protein was mixed with 4X SDS PAGE loading dye (Appendix B) to a
total volume of 10µL. The mixtures were heated to 92˚C for 5 minutes and then chilled on ice for
5 minutes. A 4% stacking 15% separating, discontinuous SDS-PAGE gel was cast and pre-run
for 30 minutes in 500mL 1X glycine buffer (diluted from 10X glycine buffer, Appendix B) at
165V(Table 4). The samples were loaded and ran at 180V until the dye-front was ¼ the length of
the gel from the bottom.

Table 4: 4% Stacking 15% Resolving Discontinuous SDS-PAGE Gel

Polyvinylidene fluoride (PVDF) membrane was cut wide enough for all protein-loaded
wells to fit; and long enough to ensure that RsmA is transferred to the membrane. The membrane
was soaked in 100% methanol for 10 minutes before transferring. Meanwhile, 1X Towbin
Electroblotting buffer prepared (Appendix B). Four sheets (two thick and two thin) of
electroblotting paper were cut slightly larger than the PVDF membrane and soaked in
electroblotting buffer. Once the gel had run a sufficient time, it was removed from the casting
cassette and trimmed with a razorblade to remove excess gel. The electroblotting paper, PVDF
membrane, and gel were assembled on a semi-dry electroblotting apparatus to transfer the
proteins from the gel to the PVDF membrane. The proteins were transferred at 115mA for 90
minutes.
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After transferring, the electroblotting apparatus was disassembled and the membrane was
placed in 50mL of Blocking Buffer (Appendix B) and rocked for 2 hours at room temperature or
overnight at 4˚C. The Blocking Buffer was poured off and replaced with 50mL of the Primary
Antibody(1˚Ab) solution (Appendix B). The 1˚Ab was rocked for at least one hour at room
temperature or overnight at 4˚C. The 1˚Ab was removed, and the membrane was washed with
50mL with Washing Buffer (Appendix B) for 15 minutes, three times. The Secondary
Antibody(2˚Ab) solution was added and rocked for 1 hour at room temperature. The 2˚Ab was
removed and the membrane was washed again following the same procedure.
In order to visualize the HA tagged proteins on the membrane a substrate must be added
for the horseradish peroxidase to cleave. The Pierce™ ECL Western Blotting Substrate Kit was
used to provide that substrate. A 3mL solution was made by mixing Detection Reagent 1
(peroxide solution) and Detection Reagent 2 (luminol enhancer) in a 1:1 ratio. The solution was
pipetted evenly over the membrane and allowed to react for 10 minutes. Finally, the RsmA HA
epitope tagged proteins were visualized using the Bio-Rad ChemiDoc™ Imaging System.

Statistical Analysis
Β-galactosidase assays were performed in technical and biological triplicate, resulting in
a sample size of nine (n=9) for each strain in each assay. Western Blots were performed in
biological triplicate (n=3). Values determined from assays were averaged and the standard error
of the mean was determined to produce error bars. The Student’s T-Test was used to determine
statistical significance among experimental strains and are reported in figure legends.
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CHAPTER 3
RESULTS
The rsmA mRNA Transcript is Under Post-Transcriptional Regulation
The aim of this study was to investigate the possibility that RsmA is posttranscriptionally regulated. Initially, two lacZ translational leader fusions were constructed to
establish the reporter activity from the two rsmA promoters. In both cases, the native promoter
regions were replaced with the constitutively active lacUV5 promoter. Replacing the native
promoters with lacUV5 removes variation caused by differing strengths of the native promoters
(i.e. normalizing transcription by removing variation due to levels of AlgU and RpoD). Each
fusion contains the native rsmA RBS, start codon (plus six additional codons), and the lacZ gene.
For the first fusion, the lacUV5 promoter was placed upstream of the AlgU dependent TSS;
henceforth referred to as the distal fusion (Figure 7. B.). The second fusion was constructed with
the lacUV5 promoter upstream of the RpoD dependent TSS (Figure 7. B.). This will be referred
to as the proximal fusion. Both fusion constructs were introduced into the chromosomes of
PAO1 and mucA22 at the attB site and analyzed via β-galactosidase assay.
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Figure 7. The RsmA mRNA Transcript is Under Post-Transcriptional Regulation. A.) Schematic
of the intergenic regions between lysC and rsmA. The AlgU and RpoD dependent promoters are
indicated by the underlined sequences. Transcriptional start sites are bolded with bent arrows
overtop at -40 and -86. B.) Schematic of the Distal and Proximal leader fusions with the lacUV5
promoter replacing the native promoters. Transcriptional start sites are bolded at -40 and -86 and
the Ribosomal Binding Site is designated RBS. C.) Leader fusions were designed and introduced
into the PAO1 and mucA22 chromosomes. Both fusions were analyzed by β-Galactosidase assay.
Assays were performed in triplicate with 8 hour LB broth cultures. Statistical analysis of
expression: mucA22 Distal vs. mucA22 Proximal: p<0.001, PAO1 Distal vs. PAO1 Proximal: p<0.001, mucA22 Proximal vs. PAO1 Proximal: p<0.001.
The distal fusion in PAO1 exhibited no reporter activity, while the proximal fusion
expressed 2017 Miller Units (Figure 7.B). The same trend was seen between the two fusions in
mucA22. Although, the proximal fusion expressed fewer Miller Units, 1335, than what was
observed in PAO1 (Figure 7.B). The increase in activity of PAO1 over mucA22 is statistically
significant, p<0.001, and may suggest that RsmA is needed in higher abundance in PAO1. This
result also calls into question the existence of a putative RpoD promoter since the distal fusion
contains the RpoD promoter, yet expression cannot be detected. Previously, TFs designed to
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investigate transcription from the distal promoter suggested that transcription does indeed occur
from the distal promoter (Stacey and Pritchett 2016). The lack of expression from the distal
fusion, coupled with previous transcriptional analysis, provide evidence that the mRNA
transcript of RsmA is under post-transcriptional regulation.
The 5’ Untranslated Region of the RsmA Transcript Contains Secondary Structures
Due to the length of the 5’ UTR and the results obtained from the translational leader
fusion analysis, the leader sequence was further analyzed. Bioinformatics obtained using the
DNA and RNA folding software, mFold, predicted two secondary structures to form in the 5’
UTR of the mRNA. The more 5’ secondary structure lies between the two TSSs, starting at the
third nucleotide after the distal transcriptional start site (-86) of the RsmA transcript (Figure
8.A). The structure forms a stem-loop consisting of 28 nucleotides. Seventeen nucleotides
comprise the stem and the loop is 11 nucleotides in length; with the stem having 100%
complementarity, the only exception being a one nucleotide bulge(Figure 8.B). The second
structure also forms a stem-loop. It starts 13 nucleotides upstream of the proximal TSS and
terminates immediately before the final nucleotide of the leader. The mFold output reveals that
the RBS is occluded by four uracil’s on the 5’ stem of the second stem-loop. Low
complementarity of the bases in the stem of the second stem-loop raises doubts on whether the
second stem-loop is stable (Figure 8.B). The bioinformatics data cannot stand alone and will
have to be further investigated using other methods.
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Figure 8. mFold Predicts the Formation of Two Stem-loops in the 5’ Untranslated Region(UTR)
of the RsmA Transcript. A.) Schematic of the 5’ UTR. Proximal and distal transcriptional start
sites(TSS) are bolded at -40 and -86, respectively. Underlined nucleotides indicate the location
of the secondary structures predicted by mFold. B.) mFold output of the RsmA 5’UTR.
Transcriptional start sites are marked at the -86 adenine and the -40 guanine. The ribosomal
binding site is underlined and labeled RBS.
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The Putative Distal Stem-loop Contributes to the Post-transcriptional Regulation of rsmA
To investigate the role of the putative distal stem-loop uncovered through bioinformatics,
non-complementary nucleotide substitutions were made within the stem using site-directed
mutagenesis. The first substitution was made at the third nucleotide of the mRNA transcript; the
most 5’ guanine at the base of the stem. The guanine was changed to an adenine and is referred
to as G3A (Figure 9. A). An increase from zero to 72 Miller Units are observed with the
substitution of just one nucleotide (Figure 9. B). Next, the first two 5’ guanines were replaced
with adenines (G3A/G4A) (Figure 9. A) and a 5-fold increase (361 Miller Units) over the initial
single nucleotide substitution was observed (Figure 9. B). The final substitutions made were
G3A/G4A/C7A/C9A (Figure 9. A). The result was a 6-fold increase (450 Miller Units) over the
initial single nucleotide substitution (Figure 9. B). The increase of expression from the distal
fusion with the nucleotide substitutions resembles a dose response curve (i.e. destabilizing the
putative distal stem-loop results in increased expression of the fusion with the build-up
nucleotide substitutions). These results suggest that the nucleotides substituted are involved in
the regulation of the RsmA transcript, although the exact mechanism cannot be determined from
this data.
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Figure 9. The Putative Distal Stem-loop Contributes to the Post-transcriptional Regulation of
RsmA. A.) mFold output of the putative stem-loop. Arrows indicate the nucleotide substituted to
adenines. B.) Distal fusions with substitutions were introduced into mucA22 and analyzed by βgalactosidase assay. (*** p<0.001) (** p<0.01)
Translation of the RsmA Transcript is Not Attributed to the GacS/GacA TCS or RsmA
To determine if translation was inhibited by the GacS/GacA TCS or if RsmA was in a
self-regulated feedback loop, I examined the distal fusion in gacA and rsmA single mutants in
PAO1 and mucA22. The data obtained from the distal fusion in the gacA and rsmA single
mutants mirrored the observation of the distal fusion in the wildtype strains. Since the Miller
Unit equation uses time (t) as a variable, assays that take several hours and never produce a
yellow pigment can result in reduced, or in this case, negative Miller Unit values (Giacomini et
al. 1992). These data suggest that translation of the RsmA transcript is not influenced by the
GacS/GacA TCS and that RsmA does not act as a translational repressor of its own message
based on fusion design in this study. Tabulated raw data can be view in Table 7 of Appendix C.
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The Putative Stem-loops are Not RNA Thermometers
To evaluate whether the putative stem-loops were temperature sensitive, PAO1 and
mucA22 harboring the distal fusion was grown at 30˚C, 37˚C, and 42˚C and evaluated by βgalactosidase assay (Figure 10). In both PAO1 and mucA22 report activity was near
undetectable levels at all temperatures tested. Reporter activity was completely undetectable in
mucA22 at 42˚C. These data suggest that the putative stem-loops are not RNA thermometers
under the growth conditions that they were tested.

Figure 10. The Putative Stem-loops are Not RNA Thermometers. PAO1 and mucA22 were grown
at 30˚C, 37˚C, and 42˚C and examined via β-galactosidase assay. Reporter activity was near
undetectable levels in both strains at all temperatures tested. No significant difference was found
between the different growth temperatures.
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Western Blot Analysis Provides Insight into RsmA Levels Among 5’ UTR Mutants
The 5’ Untranslated Region (UTR) was mutated by Site-Directed Mutagenesis (SDM) in
the region of the putative distal stem-loop and flanking region. Three different mutations were
designed to investigate if the UTR between the two putative promoters affected RsmA levels in
vivo. The suicide vector pEX18gm containing the rsmA coding region with a 3’ hemagglutinin
(HA) tag (pEX18gmrsmAHA) with 1kb flanking either side of rsmA was used as template for the
construction of the 5’ UTR deletion mutants. All three mutant constructs used a common
forward primer. As a consequence, the putative RpoD -35 has been deleted in all mutants but
maintain the putative RpoD -10 plus four nucleotides directly upstream (gcca). Three different
reverse primers were used to make various mutations (Figure 11. A). Deletions made in Mutant 1
include: the last two nucleotides of the AlgU -10 promoter, the distal TSS, the stem-loop, and
finally the RpoD -35 (Figure 11. B). Mutant 2 restores the AlgU -10 and distal transcriptional
start site and includes nucleotides -85 to -77 (5’ stem of the stem-loop). Mutant 2 lacks the loop,
the 3’ stem portion of the stem-loop, and the RpoD -35 (Figure 11. B). Mutant 3 removes every
nucleotide after the distal TSS through the forward primer annealing location at -54. This
mutation removes the stem-loop and the RpoD -35 (Figure 11. B). Once the constructs were
made and the correct sequences were verified, the constructs were introduced into the
chromosomes of PAO1 and mucA22 via homologous recombination, replacing the wild-type
rsmA allele. All six mutants, PAO1rsmAHA wild-type, mucA22rsmAHA wild-type, and a
negative control, PAO1 wild-type, were analyzed by western blot.
The western blot shows that RsmA is expressed to a greater extent in the mucA22 relative
to PAO1, which has been previously demonstrated in the literature (Stacey and Pritchett 2016).
PAO1 and mucA22 with the 5’ UTR mutation 1 do not express RsmA. Expression is partially
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restored in 5’UTR mutation 2 in mucA22, but RsmA remains undetectable in PAO1. RsmA in
mucA22 is restored to levels comparable to that seen in the wild-type strain the 5’ UTR mutant 3,
while PAO1 remains well below wild-type levels. The regions mutated are having various
influences on the expression of RsmA in the two backgrounds tested. The increased levels of
AlgU in the mucA22 strain can explain why there is increased expression of RsmA compared to
PAO1. Modification of the AlgU and/or RpoD promoter is likely the reason for the loss of
expression found in Mutant 1. These data also suggest that the region between the two promoters
is having a stronger influence on RsmA expression in PAO1.

(Figure 11 continued on next page.)
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Figure 11. Western Blot Reveals that Regulation of RsmA is Multi-tiered. A.) Schematic of the
5’ UTR of RsmA. The AlgU and RpoD -10 and -35 elements are underlined. The location of the
three reverse primers used are indicated by M1, M2, and M3. The location of the common
forward primer is indicated by “F.” The BamHI restriction enzyme site is marked with a dotted
underline. B.) Mutant 1, 2, and 3 genomic sequences. C.) Top panel: Western blot of PAO1 and
mucA22 wildtypes and mutants 1, 2, and 3 in both backgrounds. Bottom panel: RpoA loading
control. D.) Densitometry of PAO1 and mucA22 labeled as wildtype. Labels 1, 2, and 3
correspond to the three mutants.
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CHAPTER 4
DISCUSSION
Pseudomonas aeruginosa is an infections Gram negative bacterium found in numerous
environments and adhering to various surfaces. Pseudomonas aeruginosa has become a major
health threat over the past century because of its adaptability, intrinsic antibiotic resistance, and
its suite of virulence factors. Understanding the complex regulatory networks that control the
expression of the genes used by Pseudomonas to cause disease is necessary to develop new
treatments against this organism. Prokaryotes, as well as Eukaryotes, modify gene expression at
the transcriptional, post-transcriptional, and post-translational level. In Pseudomonas aeruginosa,
and other Pseudomonads, the post-transcriptional regulator RsmA, has implications in regulating
carbon metabolism, virulence, motility, biofilm formation, and others. Studies have taken several
approaches to determine the targets of RsmA and how RsmA is regulated at the posttranslational level; however, very few researchers have investigated the transcriptional control of
RsmA. Additionally, to my knowledge no one has investigated the possibility of posttranscriptional regulation of the RsmA transcript and this is the first study to do so. This
investigation provides evidence that the RsmA transcript is under post-transcriptional regulation
by using translational leader fusions. Using bioinformatics, this study identifies a secondary
structure in the 5’ UTR of the transcript that may provide the mechanism whereby the message is
regulated. Western blot analysis, although inconclusive, provides insight into RsmA levels in
vivo among the various 5’ UTR mutants. Analyzing the distal fusion at 30˚C, 37˚C, and 42˚C
suggests that the 5’ UTR is not an RNA thermometer. Finally, my data rules out RsmA and the
sRNAs, RsmY and RsmZ, as regulators of the RsmA transcript by analyzing the distal leader
fusion in a ∆rsmA mutant and a ∆gacA mutant in both PAO1 and mucA22.
48

In the RNase protection assay (RPA) from a previous study (Stacey and Pritchett 2016),
two RsmA transcripts of two lengths can be observed. The quantity of long to short RsmA
transcripts appear to be equal in PAO1 and also in mucA22. However, there is a proportional
increase in the amount of the shorter transcript relative to the longer transcript in the mucA22
strain, which would not be expected if the proximal TSS was strictly under the control of the
putative RpoD promoter. This observation was the first clue that the RsmA transcript could be
under post-transcriptional regulation and that the short transcript could be a processed message.
Leader Fusion Analysis and Bioinformatics Provide Evidence of Post-transcriptional Regulation.
The translational leader fusions provide compelling evidence of post-transcriptional
regulation of the RsmA transcript. The distal fusion contains the lacUV5 constitutively active
promoter in place of the AlgU dependent promoter. This allows for continuous transcription of
the message because it functions independently of activator proteins (Noel and Reznikoff 2000).
In addition to the lacUV5 promoter, the distal fusion maintains the putative RpoD promoter, and
yet, reporter activity in this fusion is undetectable in both PAO1 and mucA22. If transcription
and subsequent translation was occurring from the proximal TSS it should have been detectable
in this distal fusion. Interestingly, reporter expression is only seen in the proximal fusion. These
data and the two transcript observation in the RPA (Stacey and Pritchett 2016) support the notion
of a post-transcriptional processing event that leads to expression of RsmA.
Given the length of the UTR, at least 86 base-pairs, the possibility of post-transcriptional
regulation is greater than that of shorter (<40nt) UTRs (Svensson and Sharma 2016). mFold
predicts the formation of two stem-loops in the 5’ UTR of the RsmA transcript. The more distal
one lies between the two putative promoter. The second starts 13 nucleotides upstream of the
putative RpoD promoter and extends to the -2 nucleotide. The proximal stem-loop has low
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complementarity; however, it occludes the RBS with four uracil’s. Given that, I investigated
whether the proximal stem-loop was acting as a Four U RNA thermometer. Β-galactosidase
assays were performed using cultures of PAO1 and mucA22 grown at 30˚C, 37˚C, and 42˚C. No
difference was seen between these growth conditions. The stem-loop acting as RNA
thermometer was ruled out as a possible function.
Knowing that secondary structures have regulatory functions, I decided to perform sitedirected mutagenesis within the region of the putative distal stem-loop. Substituting nucleotides
resulted in a dose-dependent effect. An increase in reporter expression occurred with the addition
of a single and with multiple nucleotide substitutions in the distal fusion. Since changing the
nucleotide sequence led to reporter activity I questioned whether the sRNAs, RsmY and RsmZ,
or RsmA was recognizing and binding this region. Since GacA activates RsmY/Z transcription, I
analyzed the distal fusion in a ∆gacA mutant in both PAO1 and mucA22. Neither PAO1∆gacA or
the mucA22∆gacA double mutant had β-galactosidase activity, thus ruling out another possible
mechanism for post-transcriptional regulation of RsmA. To determine if RsmA was regulating
itself, I performed β-galactosidase assays on PAO1∆rsmA and mucA22∆rsmA. Again, like the
∆gacA mutant, no change was seen between the mutants and wild-type strain. One study has
shown RsmA autoregulation by translational fusion analysis and RsmA-rsmA interaction by
RNA mobility shift assay (Jean-Pierre et al. 2015). However, there results indicate that RsmA
inhibits translation by binding within the rsmA coding region. Their translational fusions extend
further into the coding region than the one used in this study. This can explain the discrepancy
between the two results. Together, these data provide compelling evidence that the RsmA
transcript is under post-transcriptional regulation and suggests that the region between the two
promoters provides a regulatory function unaffected by RsmY/Z or RsmA.
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Further experiments will have to be performed to confirm these data. For example, the
mFold output will have to be confirmed by RNA structural studies. There are several chemical
and enzymatic techniques that have been developed to analyze secondary structures in RNA. An
RNA footprinting technique using ribonuclease T1 can be employed to establish the existence of
any RNA secondary structures within the 5’ UTR, as ribonuclease T1 can only cleave single
stranded RNA (Ziehler and Engelke 2001).
Primary transcripts will have a 5’ triphosphate. If the shorter transcript observed in the
RPA is due to a post-transcriptional cleavage event, then the shorter transcript will have a
5’monophosphate. An assay like the Phosphorylation Assay by Ligation of Oligonucleotides
(PABLO) can be used to determine the 5’ phosphorylation state of the transcript (Celesnik et al.
2007).
Western Blot Reveals that Regulation of RsmA is Multi-tiered
To look at protein expression and the effect of mutations in the 5’ UTR in vivo, I
performed western blot analysis. The western blot made the role of the 5’ UTR in posttranscriptional regulation less clear as it cannot distinguish between transcriptional or posttranscriptional effects. My data supports previous observations of increased RsmA in the
mucA22 background (Stacey and Pritchett 2016) suggesting that RsmA may have a significant
role in chronic infections.
Removing the AlgU and RpoD -35 element and distal TSS in mutant one abolished
RsmA expression. This result was expected and further supports a previous experiment in our lab
(Stacey and Pritchett 2016), concluding that the interrupted region is required for RsmA
expression. The results from mutant two are more difficult to assign an explanation. This mutant
has a complete AlgU promoter, distal TSS, and the 5’ stem nucleotides of the putative stem-loop.
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Although expression of RsmA is not completely abolished in mucA22, it is still well below
wildtype expression and expression in the PAO1 strain was still undetectable. Interestingly, both
mutant one and mutant two resemble a ∆rsmA mutant phenotype when grown on PIA. ∆rsmA
mutants secrete more pyocyanin resulting in blue pigmented colonies and media. The
observation that mutant one and mutant two were blue when grown on PIA supports the western
blot data, suggesting that RsmA is not expressed in these strains. Possibly the most intriguing
results were those obtained from mutant three. The entire stem-loop and every nucleotide
upstream of the forward primer annealing location are deleted. There is only a slight difference
in expression of RsmA between wildtype and mutant three in the mucA22 background,
suggesting that the distal promoter is sufficient in activating RsmA expression in this strain.
However, the regulatory function of the putative distal stem-loop still cannot be assigned based
on this observation. RsmA expression in mutant three of PAO1 was half of that observed in the
wildtype strain and does not mirror what was seen in mucA22. This suggests that the putative
distal stem-loop has a very important function in PAO1.
The western blot data is preliminary. The mutant constructs should be redesigned to
provide consistency between the leader fusion nucleotide substitution experiment and western
blot analysis. If RsmA expression is different than wildtype, this experiment would provide even
more support that the region of the putative distal stem-loop plays a vital role in RsmA
expression in vivo. Additionally, mutant constructs using the pEX18GMrsmAHA suicide vector
should be made that would include the entire RpoD promoter to prove or disprove its existence.
SDM mutants should be made in the region that composes the proximal stem-loop to investigate
its role in RsmA expression.
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The importance of RsmA has been demonstrated in several studies. The comparison of
the transcriptome in wildtype versus a rsmA mutant has been conducted in PAO1 and PKA
strains of Pseudomonas aeruginosa (Burrowes et al. 2006; Brencic and Lory 2009). In both
cases, the regulon of RsmA has consisted of over 500 genes. However, only 67 genes were
common between the two strains in those studies. Given the observation that there is more RsmA
in the mucA22 strain begs the question of its role in chronic infections. Conducting a
transcriptomic or proteomic analysis of RsmA in the mucA22 background could provide
additional targets of RsmA and potentially new targets for treatments in chronic infecting strains.
Developing a treatment for chronic infecting strains would have a positive impact on the 70,000
individuals living with Cystic Fibrosis around the world.
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APPENDICES
Appendix A: Media
1% Agarose Gel (yields two gels)
0.5g Agarose
5mL 10X TBE (see 10X TBE)
45mL ddH2O
Heat, using microwave, for 1 minute
Add 2.7µL Ethidium Bromide before pouring into molds and container is warm to the touch
10X Vogel-Bonner Minimal Media (VBMM) Salts – 500ml
15g Trisodium Citrate
10g Citric Acid
50g K2SO4
17.5g NaNH4PO4 · 4H2O
ddH2O to 500ml
pH to 7 autoclave
Luria-Bertani (LB) 1-Liter
15g Agar
10g NaCl
10g Tryptone
5g Yeast Extract
1L ddH2O
Autoclave
Antibiotic Concentrations:
100µg/mL Ampicillin
15µg/mL Gentamycin
50µg/mL Kanamycin
10µg/mL Tetracycline
Yeast-Tryptone 10% Sucrose 1-Liter
15g Agar
10g Tryptone
5g Yeast Extract
800mL ddH2O
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Autoclave – Allow to cool
200mL 50% D-Sucrose
Yeast-Tryptone tet50 irg25 1-Liter
15g Agar
10g Tryptone
5g Yeast Extract
25mg Irgasan
Autoclave
50µg/mL Tetracycline
Pseudomonas Isolation Agar (PIA) 1-Liter
13.6g Agar
20mL Glycerol (2%)
25mg Irgasan
10g K2SO4
1.4g MgCl2
20g Peptone
980mL ddH2O
Autoclave
Antibiotic Concentrations:
150µg/mL Gentamycin
Vogel-Bonner Minimal Media (VBMM) 1- Liter
450ml ddH2O
7.5g Agar
Autoclave then allow to cool to ~50˚C
50ml 10X VBMM salts
500µl 1M MgSO4
50µl 1M CaCl2
Antibiotics:
300µg/ml Carbenicillin
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Appendix B: Buffers
0.5M Tris pH 6.8
6.1g Tris base
90ml ddH2O
pH to 6.8 with 12N HCl
ddH2O 100ml
1.5M Tris pH 8.8
23.6g Tris base
90ml ddH2O
pH to 8.8 with 12N HCl
ddH2O to 100ml
10X Glycine Running Buffer
144.1g glycine
10g Sodium dodecyl sulfate (SDS)
30.3 Tris base
ddH2O to 1 liter
10X TBE
55g Boric Acid
40ml 0.5M EDTA
108g Tris base
ddH2O to 1 liter
10X TBS
8.76g NaCl
2.42g Tris base
ddH2O to 100ml
10X TE
55g EDTA
108g Tris base
ddH2O to 1 liter
10X TNE
3.7g EDTA
116.8g NaCl
12.1g Tris base
ddH2O to 1 liter
10X Towbin Electroblotting Buffer
144g glycine
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30.3g Tris base
ddH2O to 1 liter
4X SDS Loading Buffer
0.5mL β-mercaptoethanol
0.5mL 1% Bromophenol Blue
2.2mL 20% SDS
4.4mL 0.5M Tris HCL pH6.8
4.4mL Glycerol
Store at -20˚C
1X TBS-T
100ml 10X TBS
500µl of Tween 20
ddH2O to 1 liter
1X Towbin Electroblotting Buffer
10ml 10X Towbin Electroblotting buffer
20ml Methanol
70ml ddH2O
1˚ Antibody Wash
5ml TBS-T buffer
45ml ddH2O
2.5µl mouse/anti-HA antibody (1: 10,000)
2˚ Antibody Wash
5ml TBS-T buffer
45ml ddH2O
2.5µl goat/anti-mouse antibody with conjugated horseradish peroxidase (1:10,000)
Blocking Buffer
2.5g Skim milk powder
5ml 1X TBS-T buffer
45ml ddH2O
Washing Buffer
5ml 1X TBS-T
45ml ddH2O
Z buffer
750mg KCl
246mg MgSO4· 7H2O
16.1g Na2HPO4 · 7H2O
5.5g NaH2PO4 · 4H2O
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ddH2O to 1 liter
pH to 7
*β-galactosidase assay: add 2.7µl/ml β-mercaptoethanol before use.
30% (v/v) Glycerol
30mL Glycerol
70mL ddH2O
Autoclave
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Appendix C: Supplemental Material
5’ UTR Mutant 1
N/A
5’ UTR Mutant 2
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5’ UTR Mutant 3

Table 5. Primers
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Table 6. Plasmids

Table 7. gacA and rsmA Single Mutant Leader Fusion Tabulated Raw Data

Site-Directed Mutagenesis Conformation Agarose Gel

All PCR products were digested with BamHI prior to visualizing on the agarose gel. Lanes 2 and
6 contain PAO1rsmAHA and mucA22rsmAHA, respectively, and digest into two bands because
the BamHI site has not been deleted from the construct. Lane 1: 2-log Ladder. Lanes 2-5:
PAO1rsmAHA, PAO1rsmAHA 5’ UTR Mutant 1, PAO1rsmAHA 5’ UTR Mutant 2,
PAO1rsmAHA 5’ UTR Mutant 3, respectively. Lane 6-9: mucA22rsmAHA, mucA22rsmAHA 5’
UTR mutant 1, mucA22rsmAHA 5’ UTR mutant 2, mucA22rsmAHA 5’ UTR mutant3,
respectively.
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